Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 160,821 | 211,845 | 196,321 | 199,091 | 186,136 |
| Marketable Securities | 70,351 | 67,135 | 38,740 | 32,463 | 90,108 |
| Receivables | 202,095 | 152,896 | 147,548 | 145,385 | 157,790 |
| Inventories | 128,283 | 121,858 | 117,366 | 116,748 | 109,990 |
| Other current assets | 31,558 | 36,496 | 43,773 | 16,919 | 22,582 |
| TOTAL | $593,108 | $590,230 | $543,748 | $510,606 | $566,606 |
| Non-Current Assets | |||||
| PPE Net | 218,398 | 211,814 | 207,134 | 207,907 | 198,975 |
| Intangibles | 1,378,960 | 1,401,403 | 1,436,320 | 1,459,035 | 1,235,638 |
| Other Non-Current Assets | 109,426 | 101,399 | 82,985 | 85,409 | 83,423 |
| TOTAL | $1,706,784 | $1,714,616 | $1,726,439 | $1,752,351 | $1,518,036 |
| Total Assets | $2,299,892 | $2,304,846 | $2,270,187 | $2,262,957 | $2,084,642 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,500 | 12,500 | 12,500 | 12,500 | 12,500 |
| Accounts payable and accrued liabilities | 30,859 | 28,756 | 30,621 | 33,384 | 30,912 |
| Accrued Expenses | 75,640 | 62,912 | 49,632 | 66,576 | 58,957 |
| Other current liabilities | 26,187 | 24,548 | 22,733 | 22,886 | 21,295 |
| TOTAL | $166,838 | $154,809 | $133,992 | $152,284 | $137,640 |
| Non-Current Liabilities | |||||
| Long Term Debt | 246,514 | 269,618 | 287,723 | 328,827 | 202,931 |
| Other Non-Current Liabilities | 74,512 | 84,579 | 103,339 | 117,802 | 98,108 |
| TOTAL | $419,732 | $447,506 | $489,240 | $539,439 | $399,060 |
| Total Liabilities | $586,570 | $602,315 | $623,232 | $691,723 | $536,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 156,934 | 157,153 | 157,181 | 156,318 | 155,567 |
| Common Shares | 393 | 393 | 393 | 390 | 389 |
| Retained earnings | 1,132,807 | 1,145,641 | 1,119,337 | 1,085,461 | 1,088,788 |
| Other shareholders' equity | -56,199 | -59,932 | -56,626 | -49,028 | -55,534 |
| TOTAL | $1,713,322 | $1,702,531 | $1,646,955 | $1,571,234 | $1,547,942 |
| Total Liabilities And Equity | $2,299,892 | $2,304,846 | $2,270,187 | $2,262,957 | $2,084,642 |